4ml semaglutide 129.00 | --- 10 mg / 4 ml --- 4 ml vial --- Weight Loss Glucagon-Like Peptide-1 (GLP-1) Semaglutide / Pyridoxine GLP-1 Injection
Description
It causes a person to have repeated seizures

A 2024 study of more than 16,000 patients found that using semaglutide drugs like Wegovy or Ozempic was associated with increased diagnoses of NAION

Drugs able to activate a number of receptors seem to perform better

Also, it activates the Peroxisome proliferator-activated receptor (PPAR)-gamma, which helps in the transcription of a few key target genes such as nuclear factor B, signal transducers, and activators of transcription that help in the control of intestinal inflammation

This approach aligns well with the appetite-suppressing effects of GLP-1 medications, which naturally reduce hunger and promote earlier satiety

Life (Basel) 2022, 12(11)
